The response to the COVID-19 pandemic has put the UK Government and NHS on an emergency footing. With this substantial change to NHS services, there has been a rapid growth in published guidelines and policy to help Healthcare Professionals (HCPs) ensure patients get the right treatment and care. Here we have detailed some key sources of information and the more important guidelines that will affect the myeloma community.
Myeloma Specific Guidelines and Information
Information specifically related to myeloma and COVID-19.
Cancer Treatment and Care Guidelines
Information relating to the management of cancer treatment and care during the COVID-19 pandemic.
England, Wales and Northern Ireland
General COVID 19 Guidelines
Myeloma patients, including those in remission, were specifically referenced as being extremely vulnerable to COVID-19 and were advised to shield.
Guidance and Information from professional organisations
This page is regularly updated with the latest guidance and information.
Last update: 21 April 2020